Author:
Singh Jagmeet P.,Walsh Mary Norine,Kubo Spencer H.,Auricchio Angelo,Delnoy Peter Paul,Gold Michael R.,Sanders Prashanthan,Lindenfeld JoAnn,Rinaldi Christopher A,Ullery Steven
Subject
Cardiology and Cardiovascular Medicine
Reference12 articles.
1. Design and rationale for the Stimulation of the Left Ventricular Endocardium for Cardiac Resynchronization Therapy in non-responders and previously untreatable patients (SOLVE-CRT) trial;Singh;Am Heart J,2019
2. Breakthrough devices program: guidance for industry and food and drug administration staff. 2018; Available at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/breakthrough-devices-program.
3. FDA guidance on conduct of clinical trials of medical products during COVID-19 public health emergency: guidance for industry, investigators, and institutional review boards. 2020; Updated Sept 21, 2020; Available at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/fda-guidance-conduct-clinical-trials-medical-products-during-covid-19-public-health-emergency.
4. Superior Vena Cava Defibrillator Coils Make Transvenous Lead Extraction More Challenging and Riskier
5. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure;Abraham;Circulation,2004
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献